D

PreveCeutical Medical Inc. PREV

CNSX
Recommendation
Dividend Power Score
Day's Range
$0.02$0.02
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

PREV Rating

Reward
Risk

PREV Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

PREV Company Overview

PreveCeutical Medical Inc. is a Canadian health sciences company focused on developing preventive and therapeutic health products and drug delivery technologies. The company operates primarily in the biotechnology and pharmaceutical research sectors, with an emphasis on cannabinoid-based therapeutics, peptide research, and advanced drug delivery systems. Its activities have historically centered on developing non-invasive delivery methods and novel formulations intended for neurological, pain management, and chronic disease applications.

The company’s principal business lines have included research programs involving its Sol-gel drug delivery platform, cannabinoid formulations, and “nature identical” peptide technologies. PreveCeutical has also explored oral and nasal delivery mechanisms designed to improve bioavailability and patient compliance. The company has positioned itself as an early-stage biotechnology developer seeking to commercialize intellectual property through licensing, partnerships, and future therapeutic commercialization. Public disclosures indicate that the company evolved from a broader preventive health and nutraceutical focus toward more specialized biotechnology and pharmaceutical development activities.

Data compiled by narrative technology. May contain errors.
Sector

PREV Income Statement

Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

PREV Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

PREV Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

PREV Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

PREV Valuation

Market Cap
Market Cap Rank
#14,981
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)

PREV Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

PREV Corporate Info

Phone Number
604 416 7777
Address
5428 Marine Drive
West Vancouver, BC V7W 2R2
Country
Year Founded
--

PREV Filings

Filing Date
Friday, August 28, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Beginning of December (est)

PREV Headlines

There are no news to display.